Literature DB >> 7833553

Epidemiological and serological studies in HIV-infected Ethiopian immigrants to Israel.

S Pollack1, E Ben-Porath, B Fuad, R Raz, A Etzioni.   

Abstract

In the last 10 years, Ethiopian Jews have immigrated to Israel in large numbers. Up to 1990 they came directly from their remote villages in northern Ethiopia and no HIV infection was detected in the several thousands that came. In contrast, 1.74% of approximately 14,000 new immigrant Ethiopians who arrived in 1991-92, after spending more than a year in Addis Ababa, were HIV positive. Several infants born in Israel following the latter immigration were found to be infected, whereas more than 2500 children born in Ethiopia were negative. Sexual transmission during their stay in Addis Ababa is thought to be the only route of infection, and therefore this is a newly infected population. Immunological studies revealed very low CD4 count in HIV-infected people. HIV-negative Ethiopian immigrants to Israel also have a lower CD4 count than the general Israeli population. Further studies are currently under way to look at the natural history of this particular HIV-infected group.

Entities:  

Mesh:

Year:  1994        PMID: 7833553     DOI: 10.1111/j.1651-2227.1994.tb13327.x

Source DB:  PubMed          Journal:  Acta Paediatr Suppl        ISSN: 0803-5326


  4 in total

1.  Immunohematological reference ranges for adult Ethiopians.

Authors:  A Tsegaye; T Messele; T Tilahun; E Hailu; T Sahlu; R Doorly; A L Fontanet; T F Rinke de Wit
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Immunohematological reference ranges for adults from the Central African Republic.

Authors:  Didier Menard; Marie Joelle Mandeng; Mesmin Bem Tothy; Eric Kassa Kelembho; Gérard Gresenguet; Antoine Talarmin
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

Review 3.  Infectious diseases among Ethiopian immigrants in Israel: a descriptive literature review.

Authors:  Yulia Treister-Goltzman; Ali Alhoashle; Roni Peleg
Journal:  Pathog Glob Health       Date:  2021-02-24       Impact factor: 2.894

4.  Comparable long-term efficacy of Lopinavir/Ritonavir and similar drug-resistance profiles in different HIV-1 subtypes.

Authors:  Zehava Grossman; Jonathan M Schapiro; Itzchak Levy; Daniel Elbirt; Michal Chowers; Klaris Riesenberg; Karen Olstein-Pops; Eduardo Shahar; Valery Istomin; Ilan Asher; Bat-Sheva Gottessman; Yonat Shemer; Hila Elinav; Gamal Hassoun; Shira Rosenberg; Diana Averbuch; Keren Machleb-Guri; Zipi Kra-Oz; Sara Radian-Sade; Hagit Rudich; Daniela Ram; Shlomo Maayan; Nancy Agmon-Levin; Zev Sthoeger
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.